Chiesi USA Inc-Strategic SWOT Analysis Review

Chiesi USA Inc-Strategic SWOT Analysis Review

  • Products Id :- GDPH138854SA
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Chiesi USA Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.


Chiesi USA Inc (Chiesi USA), formerly Cornerstone Therapeutics Inc., is a specialty pharmaceutical company. It operates as a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company research, development, production and commercialization of innovative products in the areas such as ardiovascular, respiratory, neonatology, rare disease and special care therapeutics. It focuses on commercial and development efforts in the hospital and adjacent specialty product within US. The company's product portfolio comprises, Cardene I.V., Curosurf, Zyflo, Bethkis and Retavase. It offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems and specialty pharmacies. The company markets approved generic products through the wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. Chiesi USA is headquartered at Cary, North Carolina, the US.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Section 1-About the Company 5

Chiesi USA Inc-Key Facts 5

Chiesi USA Inc-Key Employees 6

Chiesi USA Inc-Key Employee Biographies 7

Chiesi USA Inc-Major Products and Services 8

Chiesi USA Inc-History 9

Chiesi USA Inc-Company Statement 11

Chiesi USA Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Chiesi USA Inc-Business Description 13

Chiesi USA Inc-Corporate Strategy 14

Chiesi USA Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Chiesi USA Inc-Strengths 15

Chiesi USA Inc-Weaknesses 16

Chiesi USA Inc-Opportunities 17

Chiesi USA Inc-Threats 18

Chiesi USA Inc-Key Competitors 19

Section 3-Company's Lifesciences Financial Deals and Alliances 20

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 21

Chiesi USA Inc, Recent Deals Summary 22

Section 4-Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23

List of Figures

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 21

List of Tables

Chiesi USA Inc, Key Facts 5

Chiesi USA Inc, Key Employees 6

Chiesi USA Inc, Key Employee Biographies 7

Chiesi USA Inc, Major Products and Services 8

Chiesi USA Inc, History 9

Chiesi USA Inc, Subsidiaries 12

Chiesi USA Inc, Key Competitors 19

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20

Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 21

Chiesi USA Inc, Recent Deals Summary 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Windtree Therapeutics, Inc., Par Pharmaceutical Holdings, Inc., Novartis Pharmaceuticals Corporation, Lupin Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals

Chiesi USA Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 9221
Site License
USD 250 INR 18443
Corporate User License
USD 375 INR 27664



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]